Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas  Chia-Lin Hsieh, M.D.,

Slides:



Advertisements
Similar presentations
Ovarian pregnancy following intrauterine insemination
Advertisements

Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial  Renato Seracchioli, M.D., Mohamed.
Benefit of uterine artery ligation in laparoscopic myomectomy
Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors  Limor Helpman, M.D., Mario E. Beiner, M.D., Sarit Aviel-Ronen,
Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study  Nikos Vlahos, M.D., Athanasios.
Soyoung Bae, M.D., Joseph Karnitis, M.D.  Fertility and Sterility 
Yan Tang, M. D. , M. Sc. , Shi-Ling Chen, M. D. , Ph. D. , Xin Chen, M
Knut Gjelland, M. D. , Seth Granberg, M. D. , Ph. D
Risks of tubo-ovarian abscess in cases of endometrioma and assisted reproductive technologies are both under- and overreported  Claire Villette, M.D.,
Akanksha Mehta, M.D., Mark Sigman, M.D.  Fertility and Sterility 
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center  Min Zhou, M.D., Ph.D., Jin-Yun.
Michael M. Alper, M.D.  Fertility and Sterility 
Hepatitis and reproduction
Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization 
Medical treatment of ectopic pregnancy: a committee opinion
Aviad Cohen, M.D., Benny Almog, M.D., Togas Tulandi, M.D., M.H.C.M. 
Live birth of twins derived from zona-free oocytes
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Elizabeth Taylor, M.D., Christina Williams, M.D. 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Prospective evaluation of luteal phase length and natural fertility
Oocyte cryopreservation
Epidemiology and Adverse Cardiovascular Disease (CVD) Risk Profile of Polycystic Ovarian Syndrome (PCOS): The Kaiser Permanente Polycystic Ovarian Syndrome.
Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic.
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review  Seema Menon, M.D., John.
Fertility and Sterility  Volume 98, Issue 5, Pages (November 2012)
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Philipp Reif, M. D. , Wolfgang Schöll, M. D. , Philipp Klaritsch, M. D
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.
Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study  Li Wei, Ph.D., Thomas MacDonald, M.D.,
Jhansi Reddy, M.D., Marc R. Laufer, M.D.  Fertility and Sterility 
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Cervical mucus status can be accurately estimated by transvaginal ultrasound during fertility evaluation  Igal Wolman, M.D., Tamar Birenbaum Gal, M.D.,
An employer's experience with infertility coverage: a case study
Inequity between male and female coverage in state infertility laws
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Antonio La Marca, M. D. , Simone Giulini, M. D. , Giovanni Vito, M. D
Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to.
Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles  Nicolás Garrido,
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Increased secretion of amylin in women with polycystic ovary syndrome
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial  Renato Seracchioli, M.D., Mohamed.
Ovarian endometrioma vascularization in women with pelvic pain
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
Website quality assessment: Mistaking apples for oranges
Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function  S.Samuel Kim, M.D., In-Tak Hwang, M.D.,
Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
Fertility and Sterility: an evaluation
Sedigheh Borna, M.D., Azita Nasery, M.D.  Fertility and Sterility 
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Yen-Ni Teng, Ph. D. , Yung-Ming Lin, M. D. , Hsiao-Fang Sunny Sun, Ph
Ovarian cystic teratoma with a pathognomonic appearance of multiple floating balls: a case report and investigation of common characteristics of the cases.
Current evaluation of amenorrhea
Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E
In vitro sildenafil citrate use as a sperm motility stimulant
Treatment of heterotopic cervical pregnancy after in vitro fertilization–embryo transfer by using transvaginal ultrasound–guided aspiration and instillation.
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Endometrial polyps affect uterine receptivity
Is chromosome testing of the second miscarriage cost saving
Laparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery  Luigi Fedele, M.D., Stefano Bianchi, M.D., Giovanni.
Recurrence of ovarian torsion in a multiple pregnancy: conservative management via transabdominal ultrasound–guided ovarian cyst aspiration  Kathleen.
Presentation transcript:

Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas  Chia-Lin Hsieh, M.D., Chii-Shinn Shiau, M.D., Liang-Ming Lo, M.D., T'sang-T'ang Hsieh, M.D., Ming-Yang Chang, M.D.  Fertility and Sterility  Volume 91, Issue 6, Pages 2709-2713 (June 2009) DOI: 10.1016/j.fertnstert.2008.03.056 Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Kaplan-Meier survival analysis for cumulative recurrence-free rate (n = 108). The difference in recurrence-free rate was significant at the 12th month (P = .04). Fertility and Sterility 2009 91, 2709-2713DOI: (10.1016/j.fertnstert.2008.03.056) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Cyst size reduction after aspiration and sclerotherapy with ethanol irrigation (group 1) and retention (group 2). Time 0 = the day of the initial treatment. Fertility and Sterility 2009 91, 2709-2713DOI: (10.1016/j.fertnstert.2008.03.056) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions